Fate Therapeutics, Inc.
USD2.59
+0.17 (+7.02%)
CEO
Bahram Valamehr
IPO Date
2013-10-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.42
Prev. Close
$2.42
Day Low
$2.39
Day High
$2.63
52W Low
$0.91
52W High
$2.88
Market Cap
$0.30B
Volume
2.02M
| -1.0 |
| 31 Dec 2023 | FY | -147.4% | -253.3% | -43.7% | -31.8% | 0.28 | 8.48 | -2.3 |
| 31 Dec 2022 | FY | 85.7% | -292.5% | -58.2% | -39.9% | 0.23 | 4.40 | -3.5 |
| 31 Dec 2021 | FY | 89.5% | -379.9% | -31.3% | -23.0% | 0.17 | 7.79 | -26.1 |
| 31 Dec 2020 | FY | -299.6% | -551.6% | -45.1% | -27.9% | 0.25 | 5.78 | -43.2 |
| 31 Dec 2019 | FY | 100.0% | -919.0% | -40.1% | -32.5% | 0.11 | 8.17 | -13.6 |
| 31 Dec 2018 | FY | -1081.9% | -1405.0% | -41.5% | -31.3% | 0.09 | 7.53 | -10.8 |
| 31 Dec 2017 | FY | -736.8% | -1046.1% | -55.6% | -40.8% | 0.19 | 9.29 | -6.0 |
| 31 Dec 2016 | FY | -500.9% | -760.2% | -45.7% | -35.2% | 0.15 | 6.14 | -2.4 |
| -0.9 |
| 30 Sept 2025 | Q3 | 100.0% | -1852.4% | -13.8% | -9.4% | 0.34 | 7.87 | -1.2 |
| 30 Jun 2025 | Q2 | 100.0% | -1786.6% | -13.0% | -9.2% | 0.31 | 8.04 | -1.0 |
| 31 Mar 2025 | Q1 | 100.0% | -2309.5% | -13.0% | -9.4% | 0.29 | 8.81 | -0.6 |
| 31 Dec 2024 | Q4 | 100.0% | -2803.9% | -16.4% | -11.8% | 0.27 | 7.58 | -0.9 |
| 30 Sept 2024 | Q3 | 100.0% | -1551.0% | -13.2% | -9.6% | 0.27 | 8.29 | -2.2 |
| 30 Jun 2024 | Q2 | 30.3% | -567.4% | -9.7% | -7.3% | 0.25 | 9.18 | -2.5 |
| 31 Mar 2024 | Q1 | -150.4% | -2493.7% | -11.3% | -8.4% | 0.24 | 8.69 | -3.7 |
| 31 Dec 2023 | Q4 | -191.5% | -2632.6% | -12.0% | -8.7% | 0.28 | 8.48 | -2.1 |